Vemurafenib
| Vemurafenib | |
|---|---|
| Term | Vemurafenib |
| Short definition | Vemurafenib - (pronounced) (VEH-myoo-RA-feh spring) A drug used to treat Erdheim-Chester disease (a very rare form of histiocytosis) and advanced melanoma that have a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Vemurafenib - (pronounced) (VEH-myoo-RA-feh spring) A drug used to treat Erdheim-Chester disease (a very rare form of histiocytosis) and advanced melanoma that have a specific mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Vemurafenib blocks certain proteins made by the mutated BRAF gene, which can help prevent cancer cells from growing. It's a kind of kinase inhibitor. Also referred to as BRAF (V600E) kinase inhibitor RO5185426, PLX4032, RG7204 and Zelboraf
External links
- Medical encyclopedia article on Vemurafenib
- Wikipedia's article - Vemurafenib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski